ONDANSETRON AND AZITHROMYCIN: A COMMON COMBINATION THAT CAN CAUSE QT INTERVAL PROLONGATION AND VENTRICULAR ARRHYTHMIAS

被引：0
|
作者：
Kezer, Melinda [1 ]
Bobek, Mary [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH USA
来源：
CRITICAL CARE MEDICINE | 2012年 / 40卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1144
引用
收藏
页码：U309 / U310
页数：2
相关论文
共 50 条
  • [31] Prolongation of the resting QT interval in patients with left ventricular dysfunction
    Hamilton, D
    Busse, E
    Burgess, J
    Garbe, G
    Simon, A
    Klesius, A
    Abdel-Rahman, U
    Grasser, B
    Iberer, F
    Haennel, RG
    EUROPACE 2001, 2001, : 337 - 341
  • [32] COMBINATION OXALIPLATIN AND DOFETILIDE IS A HIGH RISK FOR QT INTERVAL PROLONGATION
    Antoun, Muhannad
    Moore, Scott R.
    Srivastava, Shaurya
    Pahwa, Rajit
    Jafar, Nagham L.
    Edward, Selwan O.
    Abramovitz, Aaron
    CHEST, 2022, 162 (04) : 794A - 795A
  • [33] Ondansetron/trazodone/venlafaxineSerotonin syndrome , QT interval prolongation and atrial fibrillation: case report
    Reactions Weekly, 2017, 1654 (1) : 264 - 264
  • [34] Droperidol and ondansetron-induced QT interval prolongation - A clinical drug interaction study
    Charbit, Beny
    Alvarez, Jean Claude
    Dasque, Eric
    Abe, Emuri
    Demolis, Jean Louis
    Funck-Brentano, Christian
    ANESTHESIOLOGY, 2008, 109 (02) : 206 - 212
  • [35] Droperidol and ondansetron induced QT-interval prolongation: a clinical drug interaction study
    Charbit, B.
    Alvarez, J. C.
    Demolis, J. L.
    Funck-Brentano, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 29 - 29
  • [36] INFLUENCE OF QT-PROLONGATION ON THE INCIDENCE OF VENTRICULAR ARRHYTHMIAS IN INTRACRANIAL HEMORRHAGE
    SEN, S
    STOBER, T
    BURGER, L
    ANSTATT, T
    RETTIG, G
    SCHIEFFER, H
    BETTE, L
    CIRCULATION, 1983, 68 (04) : 426 - 426
  • [37] QT interval prolongation and arrhythmias in heterozygous Merg1-targeted mice
    London, B
    Pan, XH
    Lewarchik, CM
    Lee, JS
    CIRCULATION, 1998, 98 (17) : 56 - 56
  • [38] The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients
    Avedissian, Sean N.
    Rhodes, Nathaniel J.
    Ng, Tien M. H.
    Rao, Adupa P.
    Beringer, Paul M.
    PHARMACOTHERAPY, 2019, 39 (06): : 718 - 723
  • [39] Azithromycin/hydroxychloroquineOff-label use and QT-interval prolongation: case report
    Reactions Weekly, 2020, 1830 (1) : 76 - 76
  • [40] Increased QT dispersion in the absence of QT prolongation in patients with Behcet's disease and ventricular arrhythmias
    Aytemir, K
    Ozer, N
    Aksoyek, S
    Ozcebe, O
    Kabakci, G
    Oto, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 67 (02) : 171 - 175
12345